Arthane Kodeeswaran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Arthane Kodeeswaran has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Baozhong Meng
Department of Molecular and Cellular Biology, University of Guelph , Guelph, Ontario
1 shared publication - Bonnie A. Mallard
Department of Pathobiology, University of Guelph, Guelph, ON N1G 2W1, Canada
1 shared publication - Byram W. Bridle
Department of Pathobiology, University of Guelph, Guelph, ON N1G 2W1, Canada
1 shared publication - Jacob P. van Vloten
Department of Pathobiology, University of Guelph, Guelph, ON N1G 2W1, Canada
1 shared publication - Jason P. Knapp
Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada
1 shared publication - Julia E. Kakish
Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada
1 shared publication
Latest Publications
- Open Access
- 22 August 2024
- Published by Microbiology Society in Journal of General Virology
- Vol. 105 (8) , 002010
Investigating the effect of reduced temperatures on the efficacy of rhabdovirus-based viral vector platforms
Rhabdoviral vectors can induce lysis of cancer cells. While studied almost exclusively at 37 °C, viruses are subject to a range of temperatures in vivo, including temperatures ≤31 °C. Despite potential implications, the effect of temperatures in vivo where therapeutic windows are limited.
- 22 August 2024
- Published by Microbiology Society in Journal of General Virology
- Vol. 105 (8) , 002010
Open AccessInvestigating the effect of reduced temperatures on the efficacy of rhabdovirus-based viral vector platforms
Rhabdoviral vectors can induce lysis of cancer cells. While studied almost exclusively at 37 °C, viruses are subject to a range of temperatures in vivo, including temperatures ≤31 °C. Despite potential implications, the effect of temperatures in vivo where therapeutic windows are limited.